DeepMed Research

UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Bacterial Vaginosis; A Randomized Trial to Reduce Recurrence

Not Applicable

Completed

Conditions: Bacterial Vaginosis

Interventions: Other: hygienic information plus 62% ethyl alcohol in emollient gel
Other: hygienic information

First Posted Date: 2007-10-10

Last Posted Date: 2007-10-31

Lead Sponsor: University of Washington

Target Recruit Count: 223

Registration Number: NCT00542074

Locations: 🇰🇪
Nairobi City Council STI referral clinic (Special Treatment Clinic), Nairobi, Kenya

Hormone and Information Processing Study

Phase 3

Completed

Conditions: Mild Cognitive Impairment
Alzheimer's Disease

Interventions: Drug: testosterone gel
Drug: placebo gel

First Posted Date: 2007-10-04

Last Posted Date: 2014-07-14

Lead Sponsor: University of Washington

Target Recruit Count: 22

Registration Number: NCT00539305

Locations: 🇺🇸
VA Puget Sound Health Care Systems, Seattle, Washington, United States

Automated Real-time Feedback on CPR Study

Phase 2

Completed

Conditions: Heart Arrest

Interventions: Other: Laerdal Q-CPR /technology

First Posted Date: 2007-10-04

Last Posted Date: 2012-06-25

Lead Sponsor: University of Washington

Target Recruit Count: 1586

Registration Number: NCT00539539

Locations: 🇺🇸
University of Pittsburgh, Pittsburgh, Pennsylvania, United States
🇺🇸
University of Washington, Seattle, Washington, United States
🇨🇦
The Ottawa Hospital, Thunder Bay, Ontario, Canada

HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding

Phase 2

Completed

Conditions: HIV Infections
Herpes Simplex

Interventions: Drug: valacyclovir
Drug: placebo

First Posted Date: 2007-09-17

Last Posted Date: 2018-12-19

Lead Sponsor: University of Washington

Target Recruit Count: 148

Registration Number: NCT00530777

Locations: 🇰🇪
Mathare North City Clinic, Nairobi, Kenya

Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV

Phase 4

Completed

Conditions: HIV Infection
Genital Herpes

Interventions: Drug: valacyclovir
Drug: acyclovir

First Posted Date: 2007-09-11

Last Posted Date: 2018-06-07

Lead Sponsor: University of Washington

Target Recruit Count: 28

Registration Number: NCT00527618

Locations: 🇺🇸
University of Washington Virology Research Clinic, Seattle, Washington, United States

Transcranial Magnetic Stimulation for Treating Women With Chronic Widespread Pain

Phase 2

Completed

Conditions: Fibromyalgia
Chronic Pain
Depression

Interventions: Device: rTMS
Device: Sham rTMS

First Posted Date: 2007-09-03

Last Posted Date: 2013-05-23

Lead Sponsor: University of Washington

Target Recruit Count: 19

Registration Number: NCT00524420

Locations: 🇺🇸
Harborview Medical Center, Seattle, Washington, United States

Exercise After an ICD

Phase 2

Completed

Conditions: Heart Failure, Congestive
Defibrillators, Implantable

Interventions: Behavioral: Aerobic Exercise Program

First Posted Date: 2007-08-29

Last Posted Date: 2014-11-10

Lead Sponsor: University of Washington

Target Recruit Count: 160

Registration Number: NCT00522340

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Randomized Trial of Advanced Provision Emergency Contraception Among Women With Gonorrhea or Chlamydia

Not Applicable

Completed

Conditions: Pregnancy

Interventions: Drug: levonorgestrel 0.75mg taken twice 12 hours apart (Plan B) and condoms

First Posted Date: 2007-08-24

Last Posted Date: 2007-11-15

Lead Sponsor: University of Washington

Target Recruit Count: 177

Registration Number: NCT00520455

Locations: 🇺🇸
Public Health - Seattle & King County STD Clinic, Seattle, Washington, United States

Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer

Phase 2

Completed

Conditions: Recurrent Thyroid Cancer
Stage IVA Follicular Thyroid Cancer
Stage IVA Papillary Thyroid Cancer
Stage IVB Follicular Thyroid Cancer
Stage IVB Papillary Thyroid Cancer
Stage IVC Follicular Thyroid Cancer
Stage IVC Papillary Thyroid Cancer
Thyroid Gland Medullary Carcinoma

Interventions: Drug: sunitinib malate

First Posted Date: 2007-08-23

Last Posted Date: 2017-04-25

Lead Sponsor: University of Washington

Target Recruit Count: 35

Registration Number: NCT00519896

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer

Phase 2

Completed

Conditions: Stage II Breast Cancer
Inflammatory Breast Cancer
Male Breast Cancer
Stage IIIC Breast Cancer
Stage IIIA Breast Cancer
Stage IIIB Breast Cancer

Interventions: Drug: sunitinib malate
Drug: paclitaxel
Drug: doxorubicin hydrochloride
Drug: cyclophosphamide
Biological: filgrastim
Procedure: therapeutic conventional surgery
Other: laboratory biomarker analysis
Other: flow cytometry

First Posted Date: 2007-08-09

Last Posted Date: 2019-08-07

Lead Sponsor: University of Washington

Target Recruit Count: 68

Registration Number: NCT00513695

Locations: 🇺🇸
Skagit Valley Hospital, Mount Vernon, Washington, United States
🇺🇸
Olympic Medical Center, Port Angeles, Washington, United States
🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

and more 4 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy